Bear Stearns Health Innoventures L.P

Total investments

8

Average round size

35M

Portfolio companies

7

Lead investments

2

Follow on index

0.12

Exits

5

Areas of investment
BiotechnologyHealth CareGeneticsMedicalTherapeuticsBiopharma

Summary

The venture was found in North America in United States. The main office of represented VC is situated in the New York.

Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Affymax, Raven Biotechnologies, AGY Therapeutics For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in a number of founders of portfolio startups. Among the most successful fund investment fields, there are Pharmaceutical, Medical.

This Bear Stearns Health Innoventures L.P works on 15 percentage points more the average amount of lead investments comparing to the other organizations. The important activity for fund was in 2004. The typical startup value when the investment from Bear Stearns Health Innoventures L.P is 50-100 millions dollars. Speaking about the real fund results, this VC is 69 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 investment rounds annually. The common things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2006.

The overall number of key employees were 1.

The standard case for the fund is to invest in rounds with 8-9 partakers. Despite the Bear Stearns Health Innoventures L.P, startups are often financed by Alta Partners, Sprout Group, Rho Ventures. The meaningful sponsors for the fund in investment in the same round are Sprout Group, Alta Partners, Yasuda Enterprise Development. In the next rounds fund is usually obtained by Alta Partners, Sprout Group, Yasuda Enterprise Development.

Show more

Investments analytics

Analytics

Total investments
8
Lead investments
2
Exits
5
Follow on index
0.12
Investments by industry
  • Biotechnology (8)
  • Health Care (6)
  • Medical (5)
  • Therapeutics (4)
  • Biopharma (3)
  • Show 1 more
Investments by region
  • United States (8)
Peak activity year
2004

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
22
Avg. valuation at time of investment
10M
Group Appearance index
1.00
Avg. company exit year
9

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Entelos 06 Sep 2001 Biotechnology, Health Care, Therapeutics Late Stage Venture 25M United States, California
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.